Literature DB >> 15040083

[Inhibitory action of berberine on glucose absorption].

Guo-yu Pan1, Guang-ji Wang, Jian-guo Sun, Zhi-jiang Huang, Xiao-chen Zhao, Yi Gu, Xiao-dong Liu.   

Abstract

AIM: To study the absorption characteristics of berberine and its influence on glucose absorption.
METHODS: Rat recirculating perfusion model was used to study berberine absorption characteristics and Caco-2 cell model was used to explore the influence of berberine on disaccharidase, using HPLC to assay the appearance of glucose to indicate enzyme activities.
RESULTS: Berberine was found to be hardly absorbed in the intestine (less than 5% in 2.5 h). However, sucrase and maltase activities were found to be inhibited by berberine, its ID50 to sucrase is 1.830 mg.L-1, and showed no dose dependent influence on maltase activity. Berberine also showed influence on glucose absorption. However, this effect is not significant.
CONCLUSION: Berberine may act as an alpha-glucosidase inhibitor, which is its main mechanism in diabetes treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15040083

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  12 in total

1.  In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.

Authors:  Na Yang; Run-Bin Sun; Xing-Long Chen; Le Zhen; Chun Ge; Yu-Qing Zhao; Jun He; Jian-Liang Geng; Jia-Hua Guo; Xiao-Yi Yu; Fei Fei; Si-Qi Feng; Xuan-Xuan Zhu; Hong-Bo Wang; Feng-Hua Fu; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

Review 2.  Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitus.

Authors:  Li-Xia Yang; Tong-Hua Liu; Zong-Tao Huang; Juan-E Li; Li-Li Wu
Journal:  Chin J Integr Med       Date:  2011-02-27       Impact factor: 1.978

3.  Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.

Authors:  Xiao-Yan Lv; Jing Li; Ming Zhang; Chun-Mei Wang; Zheng Fan; Chun-Yan Wang; Li Chen
Journal:  AAPS PharmSciTech       Date:  2010-03-17       Impact factor: 3.246

Review 4.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

5.  Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine.

Authors:  Shi-Chao Wei; Su Dong; Li-Jun Xu; Chen-Yu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

Review 6.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

7.  Efficacy of berberine in patients with type 2 diabetes mellitus.

Authors:  Jun Yin; Huili Xing; Jianping Ye
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

8.  The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients.

Authors:  Farzad Shidfar; Shima Seyyed Ebrahimi; Sharieh Hosseini; Iraj Heydari; Shahrzad Shidfar; Giti Hajhassani
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

Review 9.  Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Authors:  Xiaojun Feng; Antoni Sureda; Samineh Jafari; Zahra Memariani; Devesh Tewari; Giuseppe Annunziata; Luigi Barrea; Sherif T S Hassan; Karel Šmejkal; Milan Malaník; Alice Sychrová; Davide Barreca; Lovro Ziberna; Mohamad Fawzi Mahomoodally; Gokhan Zengin; Suowen Xu; Seyed Mohammad Nabavi; Ai-Zong Shen
Journal:  Theranostics       Date:  2019-03-16       Impact factor: 11.556

Review 10.  Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.

Authors:  Shengjie Yang; Dan Li; Zongliang Yu; Yujuan Li; Min Wu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.